Research News

New Therapeutic Approaches for Mucinous Ovarian Cancer

(February 13, 2019) Data from a study conducted by researchers at MD Anderson and Johns Hopkins suggest that an adjuvant gastrointestinal (GI)-based chemotherapy regimen is more beneficial than one that is gynecologic-based in patients with mucinous…

Read on

Drugs to Treat Hypertension May Enhance Ovarian Cancer Drugs

(January 23, 2019) Researchers at Massachusetts General Hospital recently found a correlation between a class of drug used to treat hypertension and longer survival rates in ovarian cancer patients when used with paclitaxel, a drug used to treat…

Read on

OCRA Awards $5.25 Million in Scientific Research Grants for 2019

(January 10, 2019) We’re pleased to announce OCRA’s newest research grants of $5.25 million to 23 top scientists at 14 top medical centers…

Read on

OCRA Funded Research Delves Deeper into How PARPi Work

(December 21, 2018) This month, researchers in Boston published their findings on how PARP inhibitors (PARPi) cause a chain reaction of responses from the tumor and its environment…

Read on

FDA Approves Olaparib for Frontline Maintenance Treatment in Ovarian Cancer

(December 20, 2018) Earlier this year a phase III clinical trial, known as SOLO-1, showed that frontline olaparib (Lynparza) can reduce the risk of disease progression or death by up to 70% in women with BRCA 1 or 2 positive, advanced stage…

Read on

Neoadjuvant Chemotherapy Recommended for Stage IV Tubo-Ovarian Cancer

(December 7, 2018) A study published last month analyzed two clinical trials that sought to determine the best first step for advanced tubo-ovarian cancers, neoadjuvant chemotherapy or debulking surgery…

Read on

Simple Cysts Found by Ultrasound Don’t Require Action

(November 16, 2018) JAMA Internal Medicine recently published an eleven year study of over 72,000 women that found having a simple ovarian cyst does not increase one’s risk of ovarian cancer…

Read on

For Some, Statin Use Can Decrease the Risk of Ovarian Cancer

(November 13, 2018) The International Journal of Cancer recently published a study that explored the use of statins, which reduces one’s lipids, and their effect on ovarian cancer risk…

Read on

World Ovarian Cancer Coalition Releases Every Woman Study Report

(October 25, 2018) Through a series of surveys, interviews, and literature reviews the World Ovarian Cancer Coalition produced a report that detailed their findings and recommendations…

Read on

Maintenance olaparib Improves Progression-Free Survival in Phase III Clinical Trial

(October 23, 2018) Olaparib, or Lynparza, was shown to increase progression-free survival (PFS) by almost three years in an ongoing trial known as SOLO-1…

Read on

OCRA Research Shows How Cancer Cells Negatively Impact the Communication between the Ovary and Fallopian Tube

(October 22, 2018) A team at the University of Illinois at Chicago, including OCRA grantee Matthew Dean, PhD, recently discovered the role that cancer cells have on their immediate environment. The research was funded in part by OCRA…

Read on

Study Looks at Long-term Survival Trends in Ovarian Cancer

(October 19, 2018) A retroactive study using SEER, or Surveillance, Epidemiology, and End Results, looked at the trends in ovarian cancer from 1983 to 2012. In almost 3 decades, the incidence of ovarian cancer per 100,000 fell from 13.7 to 10…

Read on